Pipeline

Ongoing Clinical Trials

Clinical trials are research studies designed to evaluate a new drug or combination of drugs. CanBas is currently conducting clinical trials evaluating CBP501 in combination with cisplatin and pemetrexed (Alimta®) for the treatment of advanced malignant pleural mesothelioma (MPM) and advanced non small-cell lung cancer (NSCLC).

Additional clinical trials are also ongoing in Canada, Russia, Peru, Argentina and Brazil.